Aspirin
- Product NDC
- 59779-157
- 11-digit product format
- 597790157
- Labeler code
- 59779
- Product ID
- 59779-157_90b5f6ab-f120-421d-9624-cc990316a9c8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- CVS Pharmacy
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1996-02-10
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 59779-157 | 59779-157-08 | D | Discontinued by firm | 2026-10-16 | |
| excluded package | package | 59779-157 | 59779-157-12 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 59779-157-08 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 59779-157-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 59779-157-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 59779-157-08 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 59779-157-08 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 59779-157-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 59779-157-08 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 59779-157-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 59779-157-08 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 59779-157-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 59779-157-08 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 59779-157-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 59779-157-08 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 59779-157-12 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 59779-157-08 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 59779-157-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 59779-157-08 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 59779-157-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 59779-157-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 59779-157-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 59779-157-08 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 59779-157-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 59779-157-08 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 59779-157-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspirin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59779-157-08 | Aspirin | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 21 | |
| 59779-157-08 | Aspirin | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | 21 | |
| 59779-157-12 | Aspirin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 21 | |
| 59779-157-12 | Aspirin | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 21 | |
| 59779-157-14 | Aspirin | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 21 | |
| 59779-157-85 | Aspirin | 300 in 1 BOTTLE | TABLET, FILM COATED | 300 | 21 | |
| 59779-157-90 | Aspirin | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 21 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ASPIRIN TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ASPIRIN TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ASPIRIN TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ASPIRIN TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ASPIRIN TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | 188de17c-36aa-41ae-9d84-d1b8c4ea6957 | 21 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | 188de17c-36aa-41ae-9d84-d1b8c4ea6957 | 21 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | 188de17c-36aa-41ae-9d84-d1b8c4ea6957 | 21 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | 188de17c-36aa-41ae-9d84-d1b8c4ea6957 | 21 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 59779-157-08 | 59779015708 | 1 in 1 CARTON | Historical | ||||
| 59779-157-12 | 59779015712 | 100 in 1 BOTTLE | Historical | ||||
| 59779-157-14 | 59779015714 | 500 TABLET, FILM COATED in 1 BOTTLE (59779-157-14) | 2021-03-22 | 0000-00-00 | No | No | Current |
| 59779-157-85 | 59779015785 | 300 TABLET, FILM COATED in 1 BOTTLE (59779-157-85) | 1996-02-10 | 0000-00-00 | No | No | Current |
| 59779-157-90 | 59779015790 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59779-157-90) | 1996-02-10 | 0000-00-00 | No | No | Current |